New Ventures Lead, Nordics
Anna Gran is the New Ventures Lead for the Nordics at Johnson & Johnson Innovation. She is responsible for identifying collaboration opportunities and forging partnerships between the London Innovation Centre and Nordic scientists, innovators, and entrepreneurs. She is also a local port of call for potential Nordic partners, including biotech companies, venture capital, non-profit organisations, governments, and academic institutions
Before this role, Anna was the Nordic Brand Manager for Oncology, based in Finland. In this position, she was responsible for integrating the hematology business into the Nordic Oncology team; as well as for the brand vision and strategy of two hematological cancer drugs, including leading the launch of a new drug in the Nordic region. Previously, she was Nordic Project Manager and Medical Advisor. In this role, she was responsible for medical projects and advisory throughout and after the launch of a new prostate cancer drug in Sweden, Norway, Finland and Denmark. Before Anna joined industry, she worked as a research scientist for 9 years in research teams in Finland and the Netherlands.
Anna received her Master of Science and her PhD in Biochemistry from the University of Helsinki. She received her MBA in Business Administration from the University of Cambridge- Judge Business School. Anna is also the author of several peer-reviewed articles in international life science journals.